1.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559
2.
Effect of Sustaining Lifestyle Modifications (Nonsmoking, Weight Reduction, Physical Activity, and Mediterranean Diet) After Healing of Myocardial Infarction, Percutaneous Interven...
by Booth, John N., MS
The American journal of cardiology, 2014, Vol.113 (12), p.1933-1940
3.
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma
by Iribarren, Carlos, MD, MPH, PhD
Journal of allergy and clinical immunology, 2016, Vol.139 (5), p.1489-1495.e5
4.
An Evidence-Based Review of the Cardiovascular Risks of Nonsteroidal Anti-Inflammatory Drugs
by Farkouh, Michael E., MD, MSc
The American journal of cardiology, 2009, Vol.103 (9), p.1227-1237
5.
Appropriate Cardiac Cath Lab activation: Optimizing electrocardiogram interpretation and clinical decision-making for acute ST-elevation myocardial infarction
by Rokos, Ivan C., MD
The American heart journal, 2010, Vol.160 (6), p.995-1003.e8
6.
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial
by Farkouh, Michael E., MD, MSc
The American heart journal, 2008, Vol.155 (2), p.215-223
7.
Trends in the Prevalence, Awareness, Treatment and Control of High Low Density Lipoprotein-Cholesterol Among United States Adults From 1999–2000 Through 2009–2010
by Muntner, Paul, PhD
The American journal of cardiology, 2013, Vol.112 (5), p.664-670
8.
Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette s...
by Baber, Usman, MD, MS
The American heart journal, 2013, Vol.166 (2), p.373-380.e2
9.
Prognostic Significance of Postprocedural Sustained Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI...
by Mehta, Rajendra H., MD, MS
The American journal of cardiology, 2012, Vol.109 (6), p.805-812
10.
Predictors of Stroke Associated With Coronary Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
by Domanski, Michael J., MD
The American journal of cardiology, 2015, Vol.115 (10), p.1382-1388
11.
Non-steroidal anti-inflammatory drugs and cardiovascular risk: At crossroads
by Farkouh, Michael E., MD, MSc, FRCPC, FACC, FAHA
Trends in cardiovascular medicine, 2015, Vol.25 (8), p.736-737
12.
Ability of Low Antihypertensive Medication Adherence to Predict Statin Discontinuation and Low Statin Adherence in Patients Initiating Treatment After a Coronary Event
by Muntner, Paul, PhD
The American journal of cardiology, 2014, Vol.114 (6), p.826-831
13.
Role of Insulin Resistance and Hyperglycemia in the Development of Atherosclerosis
by Bansilal, Sameer, MD
The American journal of cardiology, 2007, Vol.99 (4), p.6-14
14.
Optimal approaches to diabetic patients with multivessel disease
by Razzouk, Louai, MD, MPH
Trends in cardiovascular medicine, 2015, Vol.25 (7), p.625-631
15.
The role of primary care physician and cardiologist follow-up for low-risk patients with chest pain after emergency department assessment
by Czarnecki, Andrew, MD
The American heart journal, 2014, Vol.168 (3), p.289-295
16.
Relation of Post–Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel C...
by Domanski, Michael, MD
The American journal of cardiology, 2016, Vol.118 (11), p.1655-1660
17.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2
18.
Predictors of Low Clopidogrel Adherence Following Percutaneous Coronary Intervention
by Muntner, Paul, PhD
The American journal of cardiology, 2011, Vol.108 (6), p.822-827
19.
The Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial: Clinical and angiographic profile at study en...
by Bansilal, Sameer, MD, MS
The American heart journal, 2012, Vol.164 (4), p.591-599
20.
Serum Cystatin C and Increased Coronary Heart Disease Prevalence in US Adults Without Chronic Kidney Disease
by Muntner, Paul, PhD
The American journal of cardiology, 2008, Vol.102 (1), p.54-57
